Impaired BAX protein expression in breast cancer: Mutational analysis of the BAX and thep53 gene

This publication has 21 references indexed in Scilit:

• BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability
  Oncogene, 1998
• bax -deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis
  Proceedings of the National Academy of Sciences, 1997
• Somatic Frameshift Mutations in the BAX Gene in Colon Cancers of the Microsatellite Mutator Phenotype
  Science, 1997
• The BAX gene maps to the glioma candidate region at 19q13.3, but is not altered in human gliomas
  Cancer Genetics and Cytogenetics, 1996
• Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.
  Journal of Clinical Investigation, 1996
• bcl-2/bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancer
  International Journal of Cancer, 1996
• Expression of the bcl‐2 gene family in normal and malignant breast tissue: Low bax‐α expression in tumor cells correlates with resistance towards apoptosis
  International Journal of Cancer, 1995
• A novel form of Epstein-Barr virus latency in normal B cells in vivo
  Cell, 1995
• p53 Status and the Efficacy of Cancer Therapy in Vivo
  Science, 1994
• Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
  Genomics, 1989